Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Chronic Liver Diseases Patients”

1,768 trials

Showing 20 of 1,768 results

Post-approval studies (Phase 4)Study completedNCT03098121
What this trial is testing

Efficacy and Tolerability of Grazoprevir and Elbasvir in Patients With Chronic Genotype 1 HCV and HIV Co-infection

Who this might be right for
Chronic Hepatitis C
Taoyuan General Hospital 40
Early research (Phase 1)Study completedNCT00630058
What this trial is testing

MP-424, Peginterferon Alfa 2b, and Ribavirin in Hepatitis C

Who this might be right for
Hepatitis C
Tanabe Pharma Corporation 20
Large-scale testing (Phase 3)Not Yet RecruitingNCT07588009
What this trial is testing

Phase IIIB Extension Clinical Trial of Efficacy and Safety of GST-HG141 (Nairevir) Combined With NAs in Chronic Hepatitis B

Who this might be right for
Chronic Hepatitis b
Fujian Akeylink Biotechnology Co., Ltd. 576
Not applicableUnknownNCT01776814
What this trial is testing

Comparison of the Efficacy of Entecavir and Tenofovir Monotherapy for the Treatment of Nucleos(t)Ide-naïve Patients With Chronic Hepatitis B in Korea

Who this might be right for
Chronic Hepatitis B
Gachon University Gil Medical Center 100
Not applicableLooking for participantsNCT06406244
What this trial is testing

Efficacy of TEAS on Chronic Pain and Survival in Patients Undergoing Hepatectomy

Who this might be right for
Liver Cancer
West China Hospital 524
Large-scale testing (Phase 3)Study completedNCT01492426
What this trial is testing

Study Comparing Daclatasvir (BMS-790052) With Telaprevir Combined With Peginterferon Alfa-2a and Ribavirin in Patients With Chronic Hepatitis C Virus Infection

Who this might be right for
Hepatitis C
Bristol-Myers Squibb 605
Not applicableStudy completedNCT01442311
What this trial is testing

Directly Observed Hepatitis C Treatment in Methadone Clinics

Who this might be right for
Hepatitis CMedication Adherence
Albert Einstein College of Medicine 80
Early research (Phase 1)Study completedNCT00962871
What this trial is testing

Early Immunologic Response in Asian Patients With Chronic Hepatitis B, Treated With Pegasys (Peginterferon Alfa-2a (40KD)), Nucleoside Analogues, or Both

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 30
Post-approval studies (Phase 4)Study completedNCT00487747
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis B.

Who this might be right for
Hepatitis B, Chronic
Hoffmann-La Roche 18
Not applicableUnknownNCT06009250
What this trial is testing

Prevalence of Non-alcoholic Fatty Liver Disease in Patients With Chronic Kidney Disease in Assiut

Who this might be right for
CKDNAFLD
Muhammad Ameen Abdelrady Abdelaziz 200
Early research (Phase 1)Not Yet RecruitingNCT06661148
What this trial is testing

Study of EPI-003 in Select Nucleos(t)Ide Analogue-Treated, Chronic Hepatitis B Patients

Who this might be right for
Chronic Hepatitis BHBV (Hepatitis B Virus)
Epigenic Therapeutics, Inc 36
Post-approval studies (Phase 4)UnknownNCT04243655
What this trial is testing

Use of HA 330-II for Hemofiltration in Patients With ALF as a Bridge to Liver Transplantation .

Who this might be right for
Acute-On-Chronic Liver Failure
Asian Institute of Gastroenterology, India 10
Early research (Phase 1)Study completedNCT02496897
What this trial is testing

Phase I Safety and Immunogenicity of FP-02.2 in Chronic Hepatitis B

Who this might be right for
Hepatitis B
Altimmune, Inc. 61
Not applicableEnded earlyNCT02503735
What this trial is testing

Effect of Harvoni on Proteinuria and eGFR in Hepatitis C Virus Associated Chronic Kidney Disease (CKD)

Who this might be right for
Hepatitis CChronic Kidney Disease
Massachusetts General Hospital 14
Testing effectiveness (Phase 2)Study completedNCT00382798
What this trial is testing

Adaptive Phase I HCV Study With Nucleoside Analogue, in Combination With Interferon and Ribavirin

Who this might be right for
Healthy VolunteersHepatitis C Virus
Pharmasset 75
Large-scale testing (Phase 3)Study completedNCT01088659
What this trial is testing

Pegasys (Peginterferon Alfa 2a) Alone or in Combination With Tenofovir in Patients With Chronic Hepatitis D.

Who this might be right for
Hepatitis D, Chronic
Hoffmann-La Roche 50
Post-approval studies (Phase 4)Study completedNCT00625560
What this trial is testing

Continuing Lamivudine vs Switching to Entecavir in Patients With Detectable HBV DNA

Who this might be right for
Hepatitis B, Chronic
Yonsei University 72
Post-approval studies (Phase 4)Study completedNCT00353418
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) Plus COPEGUS (Ribavirin) in Patients With Chronic Hepatitis C (CHC) Genotype 1 and Human Immunodeficiency Virus-1 (HIV-1) Co-infection

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 415
Post-approval studies (Phase 4)WithdrawnNCT03381859
What this trial is testing

Clinical Trial to eLiminate HCV-infection in Treatment-naïve, Renally Impaired EgyptiAn Patients on Renal Dialysis, With Chronic Hepatitis C Genotype 4

Who this might be right for
Hepatitis C Virus Infection, Response to Therapy of
University of Maryland, Baltimore
Post-approval studies (Phase 4)Study completedNCT00474955
What this trial is testing

PEGASYS (Peginterferon Alfa-2a (40KD)) in Patients With Chronic Hepatitis C and Chronic Renal Failure.

Who this might be right for
Hepatitis C, Chronic
Hoffmann-La Roche 27
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation